SCHEMBL7694013

SCHEMBL7694013

COc1ccc2[nH]c(C)c(CC(=O)O)c2c1Cc1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 1/20 0.46
PTPN5 P54829 1/20 0.44
KDM4E B2RXH2 5/20 0.41
GAA P10253 4/20 0.41
MAPT P10636 3/20 0.41
ALDH1A1 P00352 2/20 0.41
TRPC5 Q9UL62 1/20 0.41
POLB P06746 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C19 P33261 2/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
LMNA P02545 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7698626 0.91 GAA (0.49) AKR1C2PTPN5KDM4EGAAMAPT
SCHEMBL7693001 0.90 AKR1C2 (0.49) AKR1C2PTPN5KDM4EGAAMAPT
SCHEMBL7699710 0.89 AKR1C2 (0.46) AKR1C2PTPN5KDM4EGAAMAPT
SCHEMBL6013487 0.89 AKR1C2 (0.46) AKR1C2PTPN5KDM4EGAAMAPT
SCHEMBL7698410 0.87 AKR1C2 (0.46) AKR1C2PTPN5KDM4EGAAMAPT
SCHEMBL5810898 0.87 PTGS1 (0.48) AKR1C2PTPN5KDM4EGAAMAPT
SCHEMBL7692673 0.87 AKR1C2 (0.45) AKR1C2PTPN5KDM4EGAAMAPT
SCHEMBL9017495 0.83 PPARG (0.46) PPARG
SCHEMBL8804815 0.82 SMN1; SMN2 (0.43) GAAMAPTALDH1A1POLBMEN1
SCHEMBL2003508 0.82 AKR1C2 (0.53) AKR1C2PTPN5KDM4EGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002020478-A1 N-BENZYLINDOLE-3-ACETIC ACID DERIVATIVES FOR USE IN THE TREATMENT OF DRUG RESISTAN CANCER DUBLIN CITY UNIVERSITY (IE) 2002-03-14 WO disclosed